Accessibility Menu
 
Novacyt logo

Novacyt

(LSE) NCYT

Current Price$48.50
Market Cap$3.52B
Since IPO (2017)-18%
5 Year-86%
1 Year+24%
1 Month+53%

Novacyt Financials at a Glance

Market Cap

$3.52B

Revenue (TTM)

$34.30M

Net Income (TTM)

$46.64M

EPS (TTM)

$-32.40

P/E Ratio

-1.50

Dividend

$0.00

Beta (Volatility)

-0.21 (Low)

Price

$48.50

Volume

355,548

Open

$52.20

Previous Close

$48.50

Daily Range

$47.61 - $52.20

52-Week Range

$26.60 - $81.60

NCYT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novacyt

Industry

Biotechnology

CEO

Lyn Dafydd Rees

Headquarters

Le Vésinet, 78140, FR

NCYT Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

-68%

Net Income Margin

-1%

Return on Equity

-66%

Return on Capital

-39%

Return on Assets

-57%

Earnings Yield

-66.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.52B

Shares Outstanding

72.59M

Volume

355.55K

Avg. Volume

354.23K

Financials (TTM)

Gross Profit

$7.88M

Operating Income

$13.17M

EBITDA

$8.21M

Operating Cash Flow

$8.75M

Capital Expenditure

$272.84K

Free Cash Flow

$9.03M

Cash & ST Invst.

$19.13M

Total Debt

$10.43M

Novacyt Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$10.25M

+0.1%

Gross Profit

$3.52M

+6.6%

Gross Margin

34.40%

N/A

Market Cap

$3.52B

N/A

Market Cap/Employee

$15.04M

N/A

Employees

234

N/A

Net Income

$16.56M

+5.6%

EBITDA

$3.85M

+72.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$8.70M

-72.5%

Accounts Receivable

$5.00M

-71.2%

Inventory

$2.53M

-15.5%

Long Term Debt

$9.58M

-18.7%

Short Term Debt

$854.68K

-36.7%

Return on Assets

-56.88%

N/A

Return on Invested Capital

-39.46%

N/A

Free Cash Flow

$3.36M

+31.6%

Operating Cash Flow

$3.28M

+27.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CREO.LCreo Medical Limited
$14.50+27.47%
POLB.LPoolbeg Pharma PLC
$5.04+1.82%
SAR.LSareum Holdings plc
$20.50-2.38%
IHC.LInspiration Healthcare Group plc
$29.30+0.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
NIONio
$5.20-0.07%
INTCIntel
$119.84+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.26+0.04%
INFQInfleqtion
$16.35+0.11%

Questions About NCYT

What is the current price of Novacyt?

Novacyt is trading at GBX 48.50 per share.

What is the 52-week range for Novacyt?

Over the past 52 weeks, Novacyt has traded between GBX 26.60 and GBX 81.60.

How much debt does Novacyt have?

As of the most recent reporting period, Novacyt reported total debt of $10.45M.

How much cash does Novacyt have on hand?

Novacyt reported $19.15M in cash and cash equivalents in its most recent financial results.

What is Novacyt’s dividend yield?

Novacyt does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.